Abstract
Few would argue that the ability to match individual patients with the safest and most effective drugs and doses would be a major advance for clinical medicine. But while clinicians have been reluctant to routinely use pharmacogenomic analyses to guide their prescribing practices, pharmacy benefit managers and drugstores are proceeding with major pharmacogenetic initiatives.
Footnotes
Citation: E. J. Topol, Pharmacy benefit managers, pharmacies, and pharmacogenomic testing: Prescription for progress? Sci. Transl. Med. 2, 44cm22 (2010).
- Copyright © 2010, American Association for the Advancement of Science
